The store will not work correctly when cookies are disabled.
[((3S)-3-Amino-3-carboxy)propyl][(5-nitrothiophen-3-yl)hydroxymethyl]phosphinic Acid
ID: ALA4061423
PubChem CID: 92044496
Max Phase: Preclinical
Molecular Formula: C9H13N2O7PS
Molecular Weight: 324.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N[C@@H](CCP(=O)(O)C(O)c1csc([N+](=O)[O-])c1)C(=O)O
Standard InChI: InChI=1S/C9H13N2O7PS/c10-6(8(12)13)1-2-19(17,18)9(14)5-3-7(11(15)16)20-4-5/h3-4,6,9,14H,1-2,10H2,(H,12,13)(H,17,18)/t6-,9?/m0/s1
Standard InChI Key: GDELUTDICYGXSV-AADKRJSRSA-N
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
8.1615 -11.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9642 -11.4847 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.3598 -10.7696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7992 -10.1716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0616 -10.5214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3455 -10.1278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3283 -9.3108 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6465 -10.5512 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
5.9304 -10.1575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2314 -10.5809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5153 -10.1873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8163 -10.6107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4981 -9.3703 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1002 -10.2170 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8335 -11.4277 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6407 -9.7320 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6407 -11.3664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1708 -10.6686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6637 -11.3204 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4888 -9.9158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
5 6 1 0
6 7 1 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 1 1
12 14 1 0
12 15 2 0
8 16 2 0
8 17 1 0
3 18 1 0
18 19 1 0
18 20 2 0
M CHG 2 18 1 19 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.25 | Molecular Weight (Monoisotopic): 324.0181 | AlogP: 0.72 | #Rotatable Bonds: 7 |
Polar Surface Area: 163.99 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.05 | CX Basic pKa: 9.53 | CX LogP: -2.12 | CX LogD: -5.26 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.32 | Np Likeness Score: -0.16 |
References
1. Selvam C, Lemasson IA, Brabet I, Oueslati N, Karaman B, Cabaye A, Tora AS, Commare B, Courtiol T, Cesarini S, McCort-Tranchepain I, Rigault D, Mony L, Bessiron T, McLean H, Leroux FR, Colobert F, Daniel H, Goupil-Lamy A, Bertrand HO, Goudet C, Pin JP, Acher FC.. (2018) Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites., 61 (5): [PMID:29397723] [10.1021/acs.jmedchem.7b01438] |